Ekaterina A. Alekseeva

Ekaterina A. Alekseeva

Auto-generated profile, based on publicly available information

Ekaterina A. Alekseeva

Sechenov First Moscow State Medical University; National Medical Research Center for Children’s Health

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2022 in Advances in molecular oncology
Verified
Journal Article
Open access
PDF file
Ekaterina VetchinkinaEkaterina Vetchinkina
Ekaterina Vetchinkina
AKAlexey Kalinkin
Alexey Kalinkin
EKE. B. Kuznetsova
E. B. Kuznetsova
AKAlevtina Kiseleva
Alevtina Kiseleva
EAE. A. Alekseeva
E. A. Alekseeva
IBIrina Bure
Irina Bure
Introduction. Gastric cancer remains one of the most common cancers and has a high mortality rate worldwide. Epigenetic alternations of non-coding RNAs (ncRNAs), including microRNAs and long ncRNAs can contribute to its pathogenesis and progression, and could be potent diagnostic and prognostic biomarkers.Aim. Estimation of PROX1‑AS1 and miR-647 expression in gastric cancer and investigation of its clinical significance. Materials and methods. Tumor and adjacent normal tissues (n = 62), and sectional normal tissue samples (n = 5) were included in the study. The expression of the ncRNAs was quantified by reverse transcription-polymerase chain reaction assay.Results. We have reviled the significant difference in the PROX1‑AS1 expression in tumor (p = 0.002) and non-tumor tissues (p 0.001) obtained from gastric cancer patients in comparison with sectional gastric tissues without pathology. Pearson correlation analysis confirmed a negative correlation between PROX1‑AS1 and miR-647 in gastric cancer both in tumor (р 0,001) and adjacent normal tissues (р 0.001). Besides, expression of PROX1‑AS1 and miR-647 was associated with the size and extent of the primary tumor.Conclusion. The obtained results allow to suggest a potential prognostic value of PROX1‑AS1 and miR-647 in gastric cancer.

15 August 2022 in Cancer Urology
Verified
Journal Article
Open access
PDF file
MFM. G. Filippova
M. G. Filippova
DMDmitry S. Mikhaylenko
Dmitry S. Mikhaylenko
ISIgor Samoylenko
Igor Samoylenko
YSYu. S. Sergeev
Yu. S. Sergeev
NKN. A. Kozlov
N. A. Kozlov
EAE. A. Alekseeva
E. A. Alekseeva
This article presents a case report of hereditary leiomyomatosis and renal cell cancer (HLRCC) with new mutation in a 25-year-old female patient admitted to the clinic for diagnosis and treatment due to multiple skin and uterus leiomyomas. The patient has a history of surgery to remove adrenal pheochromocytoma and papillary kidney cancer. Clinical and laboratory examination as well as medical genetic counseling of the patient were performed. We have detected the heterozygous c.395_399del (p.L132*) germline nonsense mutation in exon 4 of the FH gene using polymerase chain reaction/Sanger sequencing of exons 1–10 of this gene and confirmed the diagnosis of HLRCC. The mutation c.395_399del in a patient with HLRCC was described for the first time. The identical mutation was also found in the mother and sister of the patient. Based on the obtained results, medical genetic counseling was carried out in this family, recommendations were given for further oncological monitoring. The case report could be useful for geneticists, oncologists and other specialists to interpretate the clinical heterogeneity of HLRCC and improve the genetic diagnosis of this rare hereditary oncological syndrome.

12 August 2026 in Russian Journal of Pediatric Hematology and Oncology
Verified
Journal Article
Open access
PDF file
TUTatiana Ushakova
Tatiana Ushakova
SKS. K. Karimova
S. K. Karimova
EAE. A. Alekseeva
E. A. Alekseeva
VPV. G. Polyakov
V. G. Polyakov
ТУТ. Л. Ушакова
Т. Л. Ушакова
ВПВ. Г. Поляков
В. Г. Поляков
Retinoblastoma (RB) is one of the most common malignant intraocular tumors in children. The incidence rate of RB in the world is 1 case per 16,000–18,000 live newborns. In the absence of access to genomic biomarkers, ophthalmologists strictly rely on clinical signs when making therapeutic decisions. Knowledge of the genetic nature and molecular features of RB can provide a more objective understanding of the disease as a whole, conducting early diagnosis, predicting the course of the disease, including assessing the therapeutic response of the tumor to treatment. This makes it possible to individualize patient management tactics aimed at preserving life, and, importantly, preserving the organ of vision and its function. Until recently, molecular and genomic profiling of RB was limited exclusively to enucleated eyes, which was explained by the prohibition of performing a direct tumor biopsy due to the risk of extraocular spread. An alternative to a direct biopsy is a liquid biopsy. Its diagnostic potential is based on the presence of extracellular DNA in body fluids, including those of tumor origin. For patients with RB, the main material used to search for germinal mutations is blood. However, for the analysis of somatic mutations in a tumor, in the case of RB, blood is not a reliable enough material. The article provides an overview of publications on the possibilities of genomic profiling of RB using liquid biopsy. The material of choice for liquid biopsy in the case of intraocular RB was the aqueous humor of the anterior chamber of the eye in order to study the molecular genetic nature of RB in vivo.

24 September 2026 in Current Pediatrics
Verified
Journal Article
Open access
PDF file
IFIrina V. Fel’Dblyum
Irina V. Fel’Dblyum
KSKseniya A. Subbotina
Kseniya A. Subbotina
EUElena Vitalievna Uvarova
Elena Vitalievna Uvarova
NPNatalia A. Pekareva
Natalia A. Pekareva
EAEkaterina I. Alekseeva
Ekaterina I. Alekseeva
СГС. О. Голоднова
С. О. Голоднова
Background. Human papillomavirus (HPV) infection is a significant risk factor for the development of HPV-associated precancerous and malignant diseases. Recombinant adsorbed vaccine against HPV (types 6, 11, 16, and 18) has been developed in Russian Federation to prevent these conditions. Vaccine immunogenicity and safety have been studied in adults. Objective . The aim of the study is to evaluate the safety and immunogenicity of Russian recombinant adsorbed quadrivalent vaccine against HPV (types 6, 11, 16, and 18) in children aged 9–17 years in comparison to reference quadrivalent vaccine. Study design. Multicenter, randomized, double-blind, parallel-group, phase III clinical trial with a 1 : 1 participant allocation ratio. Methods. The study included healthy seronegative children aged 9–17 years. Study participants aged 9–13 years received either the investigational vaccine or the reference vaccine. Vaccine safety was assessed from April 2, 2024 to April 14, 2025, in all participants who received at least one vaccine dose (as-treated population). Any post-vaccination reactions and adverse events (AE) were recorded, their correlations with vaccination, severity, and duration were evaluated. The primary efficacy endpoint was the geometric mean titer ratio (GMT Ratio) of antibodies to HPV 1 month after full vaccination course (Per-Protocol (PP) population); additionally, the GMT Ratio was evaluated for every HPV type. Randomization was centralized and based on computer-generated list. Allocation concealment was ensured via the method of sequentially numbered, opaque, sealed envelopes. Results . A total of 705 AEs were registered during the study period, 426 of which were considered related to vaccination. No severe vaccination-related AEs were reported. The investigational vaccine demonstrated comparable immunogenicity to the reference drug across all four HPV types in both age cohorts. The seroconversion rate in PP population ranged from 97% to 100%. Higher GMT values were observed in participants aged 9–13 years compared to those aged 14–17 years. GMT values were higher in the investigational drug group in both age cohorts for HPV type 18. Conclusion . Favorable safety profile and adequate immunogenicity of the investigational vaccine were recorded compared to the reference vaccine in children aged 9–17 years. The obtained data suggest that the investigational vaccine is a promising drug for HPV-associated diseases prevention.

1 April 2026 in Current Molecular Medicine
Verified
Journal Article
Closed access
PDF file
IBIrina Bure
Irina Bure
Ekaterina VetchinkinaEkaterina Vetchinkina
Ekaterina Vetchinkina
EKEkaterina B. Kuznetsova
Ekaterina B. Kuznetsova
AKAlexey Kalinkin
Alexey Kalinkin
AMArtem D. Molchanov
Artem D. Molchanov
MNMarina V. Nemtsova
Marina V. Nemtsova
Background: Gastric cancer (GC) remains one of the most common malignancies and the third cause of cancer-related deaths worldwide. Non-coding RNAs (ncRNAs), including microRNAs and long ncRNAs, can contribute to the pathogenesis and progression of GC and therefore could be its potent diagnostic and prognostic biomarkers. The aim of our work was to estimate the expression of PROX1- AS1 (Prospero Homeobox 1 Antisense RNA 1) and miR-647 (microRNA-647) in GC and investigate their potential interaction and clinical significance. Methods: The study included tumor and adjacent non-tumor tissues from 110 GC patients and plasma samples from 65 GC patients; 38 sectional normal gastric tissue samples and 49 plasma samples of healthy donors were included as controls. Expression levels of both ncRNAs were quantified in all samples by using real-time polymerase chain reaction (RT-PCR) and their possible correlations with the clinical and pathological characteristics of patients were analyzed. A potential inverse correlation between PROХ1-AS1 and miR-647 expression was addressed by in vitro experiments in a panel of cancer cell lines. Results: The expression of PROX1-AS1 and miR-647 was not significantly different in tissues of GC patients and sectional normal gastric tissue samples. However, they have demonstrated a negative correlation both in the tumor and the adjacent nontumor tissue of GC patients. PROX1-AS1 expression was significantly decreased in GC tissues, whereas the miR-647 expression was increased. The expression of the ncRNAs was associated with clinical and pathological characteristics of GC patients. The overexpression of miR-647 led to a significant decrease in PROX1-AS1 expression in five cancer cell lines, including the GC cell line SNU-1. Conclusion: We have demonstrated a negative correlation between PROX1-AS1 and miR-647 in both GC tissues and the cancer cell lines. In addition, expression of both ncRNAs was associated with the primary tumor size. Therefore, these ncRNAs might have potential prognostic value.

15 April 2022 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
DODarya Osipova
Darya Osipova
Tatiana MarkovaTatiana Markova
Tatiana Markova
GMG.N. Matyushchenko
G.N. Matyushchenko
EAE.A. Alexeeva
E.A. Alexeeva
VSVladimir Strelnikov
Vladimir Strelnikov
EDElena L. Dadali
Elena L. Dadali
Облако Mail.ru - это ваше персональное надежное хранилище в интернете.